Biopharma Co. Lied About Hepatitis Drug, Investors Say

Biopharmaceutical company Achillion Pharmaceuticals Inc. was hit Wednesday with a proposed class action accusing the company of failing to disclose that its hepatitis drug sovaprevir doesn't interact well with certain other antiviral medications, ...read more

  • Tags: